SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-162517
Filing Date
2015-04-30
Accepted
2015-04-30 17:02:06
Documents
8
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d907882ddefa14a.htm DEFA14A 36955
2 GRAPHIC g907882naa_001.jpg GRAPHIC 8846
3 GRAPHIC g907882naa_002.jpg GRAPHIC 1569
4 GRAPHIC g907882naa_003.jpg GRAPHIC 1417
5 GRAPHIC g907882naa_004.jpg GRAPHIC 1488
6 GRAPHIC g907882naa_005.jpg GRAPHIC 1538
7 GRAPHIC g907882naa_006.jpg GRAPHIC 1674
8 GRAPHIC g907882naa_007.jpg GRAPHIC 5015
  Complete submission text file 0001193125-15-162517.txt   68705
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 15819948
SIC: 2834 Pharmaceutical Preparations